- Meeting report
- Open Access
Basic science of osteoarthritis
© The Author(s). 2016
- Received: 6 July 2016
- Accepted: 9 September 2016
- Published: 13 September 2016
Osteoarthritis (OA) is a prevalent, disabling disorder of the joints that affects a large population worldwide and for which there is no definitive cure. This review provides critical insights into the basic knowledge on OA that may lead to innovative end efficient new therapeutic regimens. While degradation of the articular cartilage is the hallmark of OA, with altered interactions between chondrocytes and compounds of the extracellular matrix, the subchondral bone has been also described as a key component of the disease, involving specific pathomechanisms controlling its initiation and progression. The identification of such events (and thus of possible targets for therapy) has been made possible by the availability of a number of animal models that aim at reproducing the human pathology, in particular large models of high tibial osteotomy (HTO). From a therapeutic point of view, mesenchymal stem cells (MSCs) represent a promising option for the treatment of OA and may be used concomitantly with functional substitutes integrating scaffolds and drugs/growth factors in tissue engineering setups. Altogether, these advances in the fundamental and experimental knowledge on OA may allow for the generation of improved, adapted therapeutic regimens to treat human OA.
- Articular cartilage
- Animal models
- Stem cells
- Tissue engineering
OA is a common condition limiting the quality of life of patients, representing a social, economic burden (Bijlsma et al. 2011). Its prevalence increases with aging and obesity. Knee OA affects over 70 million Europeans, and the direct costs exceed 2 billion euros. The disease progression is commonly slow but ultimately leads to joint malfunction as the cartilage has a poor regeneration capability. According to World Health Organization (WHO) Global Burden of Disease Study 2010, hip and knee OA is the 11th leading cause of disability.
Traditional treatments, apart from exercise and weight loss, include non-steroidal anti-inflammatory drugs (NSAIDs), supplements (glucosamine, chondroitin), viscosupplementation, arthroscopic lavage and debridement, combined non-pharmacological and pharmacological modalities, and replacement surgery as a sustainable alternative in restricted situations. Still, none of these procedures proved successful so far to fully reverse the OA phenotype in patients, mostly because the pathogenesis of the disease is still poorly understood.
Lectures of the ICL16 on May 7th, 2016 of the 17th ESSKA Congress in Barcelona, Spain
Title of lectures
Cell-matrix interface in OA
Laura de Girolamo
Animal models of OA
Stem cells in OA
J. Miguel Oliveira
Tissue engineering in OA
The bone in OA
High tibial osteotomy models
The chronological events controlling the pathology of OA are still debated but recent developments emphasized an early pathophysiological role of the subchondral bone. The subchondral bone, located immediately below the layer of calcified cartilage, forms the osteochondral unit together with the articular cartilage. The basophilic line on histological sections separating the hyaline cartilage from the underlying calcified cartilage is the tidemark while the border that separates the calcified cartilage from the subchondral bone plate is the cement line. Two parts constitute the subchondral bone. The subchondral bone plate is composed of a cortical bone plate and cancellous bone, which join together to enclose narrow intervening spaces. The highly mineralized cortical plate is made of osteon units containing a central Haversian canal with nerves and capillaries. Osteon units communicate with each other by Volkmann canals. The trabecular bone modelling medullar cavities instead have a level of mineralization of only about 15–25 % bone volume. The intervening spaces are gradually enlarged and become elongated in deeper regions of the subchondral bone, forming the subarticular spongiosa (Orth et al. 2013). Subchondral cortical and cancellous bone are architecturally, physiologically and mechanically different and respond differently in OA (Burr & Gallant 2012).
Radin and co-workers first identified the subchondral bone as a key factor in the initiation and progression of OA (Radin et al. 1970, Radin et al. 1972), showing that repetitive impulsive joint loading causes trabecular microfractures in the subchondral bone. Repair of such microfractures was thought to increase stiffness variation in the subchondral bone and in turn, cause tension and shear stress on the cartilage, ultimately leading to joint degeneration. However, several investigations revealed that the subchondral bone in OA is subjected to a decrease rather than an increase in bone stiffness (Burr 2004, Day et al. 2001). Besides, this strictly mechanical approach and the historical interpretation of the role of the subchondral bone can not explain the initial subchondral bone loss observed in early OA, do not allow for differentiation between early and late stages of the disease, and do neither address biological aspects nor the role of the calcified cartilage. Thus, a better in-depth understanding of the complex processes involved in OA is mandatory.
Current knowledge allows differentiation of two distinct pathophysiological processes: early and late stage OA. Early OA is clinically defined as the combination of joint pain, minor radiographic changes, but also presence of cartilage or subchondral bone lesions as seen by arthroscopy or magnetic resonance imaging (Luyten et al. 2012, Madry et al. 2016). Bone scintigraphic analyses (Buckland-Wright et al. 1991) or longitudinal studies following anterior cruciate ligament rupture (Buckland-Wright et al. 2000) suggest that subchondral bone changes may precede articular cartilage degeneration in OA initiation.
Remodelling processes play the crucial role in the pathogenesis of early OA and determine apparent subchondral bone changes (Burr 2004). Here, activation of secondary ossification centers, e.g. due to subchondral microfractures, results in bone resorption by osteoclasts followed by bone formation by osteoblasts. While this remodelling sequence is strictly balanced under physiological conditions, the rate of bone turnover is increased three- to fivefold in early OA (Amir et al. 1992). Importantly, in such high rates of bone turnover, the late phase of tissue mineralization is attenuated, leading to decreased bone stiffness (Goldring & Goldring 2010). Enhanced vascularization of the subchondral bone plate (Burr & Gallant 2012) causes decreased bone deposition and reduced its thickness (Intema et al. 2010). Such decreased thickness has been confirmed in canine and lapine experimental models of early OA (Bellido et al. 2011, Sniekers et al. 2008). Causes of increased bone remodelling include cellular signalling processes for microdamage repair (Funck-Brentano & Cohen-Solal 2011), stimulation of vascular invasion by angiogenic factors (Pesesse et al. 2011), and disturbed bone-cartilage crosstalk via physiological subchondral pores (Duncan et al. 1987) or pathological microcracks (Burr & Radin 2003).
The layer of calcified cartilage in normal joints is more dense than bone and thinner than the overlying hyaline articular cartilage (ratio 10:1) (Burr 2004). In early OA, the calcified cartilage layer is subjected to increased endochondral ossification (Suri & Walsh 2012), most likely triggered by vascular invasion from the subchondral bone compartment. In addition, recent experimental data suggest that hypertrophic chondrocytes within the calcified cartilage may transdifferentiate into osteoblasts, thus directly obtaining the capacity for bone formation (Yang et al. 2014, Zhou et al. 2014). Such ossification results in an accelerated advancement and duplication of the tidemark with increased thickness of the calcified cartilage layer. This process may increase the mechanical stress in the deep zones of the hyaline articular cartilage, contributing to the acceleration of OA (Goldring & Goldring 2010).
In late stage OA, the bone remodelling sequence is decreased and bone turnover is reduced. This allows for an increase in bone deposition, resulting in an enhanced thickness of the subchondral bone plate and an increased density of cortical and cancellous subchondral bone (Burr & Gallant 2012). This phenomenon is clinically known as subchondral sclerosis (Kellgren & Lawrence 1957). Interestingly, osteoblasts in late stage OA secrete a type-I collagen α1 homotrimer phenotypically distinct from the normal α1/α2 heterotrimer (Chan et al. 2011, Couchourel et al. 2009) and possessing a reduced affinity for calcium. This resolves the paradox of increased subchondral bone density relative to decreased bone mineralization and stiffness in late OA.
Early-stage OA increases remodelling and bone loss of both trabecular and cortical subchondral entities (the two parts of the subchondral bone), whereas late-stage OA decreases remodelling and increases subchondral plate densification (Burr & Gallant 2012).
Trabecular and bone plate are composed of osteocytes, osteoblasts, and osteoclasts that function in a coordinated manner during bone homeostasis. However, these cells become malfunctioning during OA and most particularly the osteoblasts that acquire an OA phenotype especially in advanced OA. Such OA osteoblastic phenotype is more marked in the subchondral bone plate than in the trabecular bone, located at one centimeter of the cortical plate (Lavigne et al. 2005), and consisting in the up-regulation of numerous genes coding for extracellular matrix proteins, secreted cytokines and growth factors, and cell membrane proteins. For instance, interleukins 6 and 8 (IL-6, IL-8), leptin, and prostaglandins E2 (PGE2) are inflammatory factors secreted in a higher amount by OA osteoblasts (Hilal et al. 1998, Lisignoli et al. 2006, Massicotte et al. 2002, Mutabaruka et al. 2010). Type-I collagen (the major protein of the osteoid matrix) as well osteocalcin and osteopontin (proteins involved in matrix mineralization) are also produced in higher quantity (Gevers & Dequeker 1987, Hilal et al. 1998, Sanchez et al. 2008). However, OA bone is undermineralized (Grynpas et al. 1991), probably due to a defect of osteoblast function (Couchourel et al. 2009, Taylor et al. 2014). One explanation of this phenomenon could be that although type-I collagen production is increased (Mansell & Bailey 1998), the presence of homotrimers of alpha 1 chain of type-I collagen (Couchourel et al. 2009) instead of the classical 2-to-1 ratio of alpha 1 and alpha 2 chains disturbs the mineralization. Dickkopf-related protein 2 (DDK2) and sclerostin (SOST) whose expression increases, while that of R-spondin 2 (R-Spo2) decreases, seem also to play a role in the hypomineralization of OA bone (Abed et al. 2011, Abed et al. 2014, Chan et al. 2011). Interestingly, DKK1 is not differentially expressed between normal and OA osteoblasts (Chan et al. 2011). In addition to these factors, some cell membrane proteins involved in the balance of inorganic pyrophosphate and phosphate ions, namely alkaline phosphatase and ANKH (an inorganic pyrophosphate transport regulator) are upregulated during OA (Hilal et al. 1998, Sanchez et al. 2008). OA osteoblasts produce high level of growth factors such as transforming growth factor beta (TGF-β) (Mansell & Bailey 1998), insulin-like growth factor I (IGF-I) (Hilal et al. 1998, Massicotte et al. 2002), and hepatocyte growth factor (HGF) (Guevremont et al. 2003) as well as leptin (Mutabaruka et al. 2010) that may intervene in the modifications of the behavior of the articular chondrocyte through diffusion via microcracks. For example, TGF-β can either stimulate (Smad1/5/8 signaling pathway) or inhibit (Smad2/3 signaling pathway) chondrocyte terminal differentiation. There is further evidence that a switch in TGF-β signaling from Smad2/3 to Smad1/5/8 signaling plays a role in altered articular chondrocyte behavior and in the development of OA (van der Kraan et al. 2009). It was also shown that HGF can upregulate the expression of collagenase 3, a very active enzyme directed against type-II collagen (Reboul et al. 2001) whereas leptin is associated with OA cartilage (Dumond et al. 2003). Although the presence of these microcracks and of a greater number of blood vessels, OA subchondral bone undergoes hypoxic conditions. Very few studies have addressed hypoxia as measuring oxygen tension in the bone is arduous. However, venous stases (Arnoldi et al. 1972) have long been reported in OA patients and have been confirmed more recently with dynamic contrast-enhanced magnetic resonance imaging (MRI) (Aaron et al. 2007) and positron electron transfer (Dyke & Aaron 2010), sometimes leading to intra-osseous hypertension (Arnoldi et al. 1972). These perfusion abnormalities have also been associated with osteonecrosis and bone marrow lesions (Aaron et al. 2007) as dynamic episodes seen with MRI, often predicting progressive OA (Driban et al. 2013, Hunter et al. 2011, Pelletier et al. 2013, Xu et al. 2012).
Hypoxic conditions induce a high level of leptin production by osteoblast particularly under the control of vitamin D (Bouvard et al. 2014).
In summary, the OA osteoblastic phenotype in cortical subchondral bone is more marked than in the trabecular one. Parathyroid hormone (PTH), IGF-I, and Wnt signaling and may be other pathways are disturbed. The right interaction between osteoblasts and the modified OA extracellular cartilage matrix (ECM) is disturbed too. TGF-β could be a key player in the process of OA in subchondral bone and hypoxia an aggravating factor of risk.
The growing interest in both the factors triggering the development of OA and the therapeutic targets enabling more effective treatments has led to the introduction of a large number of animal models, depending on the many different aspects of human pathology. Each model can indeed describe only few peculiar aspects of the pathology and should be chosen accurately so as to maximize the outcome and the translatability of each study.
Primary OA is better monitored using naturally occurring models such as spontaneous and overuse-induced OA or genetically-induced OA whereas secondary OA can be mimicked by invasive surgical techniques such as meniscectomy, anterior cruciate ligament transaction (ACLT), or by chemical induction with inflammatory mediators or degenerative agents. Animal size and features are also crucial parameters for the study design. Although small animals allow for an easier and less costly management, their restricted size and differences with the human anatomy, histology, and physiology actually represent a limit to the translatability and investigation with radiologic techniques. On the other hand, large animals offer the advantages of spontaneous or readily inducible OA and of closer similarity to the human organism but at the same time, the high costs and negative public perception represent relevant drawbacks (Gregory et al. 2012).
During a study design, it is also important to adopt the model that better represents the pathology of interest so that the most suitable analyses can be performed. In OA, the most examined joint is the knee, however some models have been developed in metacarpophalangeal (McCoy 2015) and middle carpal joints (McIlwraith et al. 2010) of horses. When treating primary OA, naturally occurring models seem better suited since the disease spontaneously arises and simulates the natural progression of human pathology. In this model, one advantage is represented by the similarity between the experimental lesions and those occurring in human patients. Several animals have been proposed including mice, guinea pigs, rabbits, dogs, sheep, goats, and horses (Kuyinu et al. 2016, McCoy 2015). Guinea pigs represent a particularly good model to study human primary OA because of its rapid onset development (Yan et al. 2014). Horses are instead the most similar model to human individuals in terms of structure and pathology features and thus represent a valid system to study bone remodeling. Nevertheless, two major drawbacks of these models are represented by the long time needed for injury development and their high costs. Another way to obtain reliable models of primary OA is to use genetically-modified animals. This approach is useful to investigate the molecular basis of OA such as the effect of pro-inflammatory cytokines on its development (Little & Hunter 2013). Still, the complexity of this multifactorial pathology reduces the translatability to clinical practice of data derived from genetically-modified animals because therapeutic interventions targeting these specific genes do not take into account other contributing genes that participate in the pathogenesis of the disease (Miller et al. 2013).
Invasive and non-invasive models
rapid induction, high reproducibility, readily available, widely described systems
rapid induction, high reproducibility, low infection risk, long time frame of OA changes, allowing for early evaluation and intervention
risk of infection, expertise needed, early changes often, undetectable because of rapid induction
not readily available, expertise needed, scarce literature
Another invasive way to induce OA is represented by the use of chemical compounds. It consists of the direct injection of toxic or inflammatory compounds into the joint such us papain, collagenase, sodium monoiodoacetate, and quinolones (bacterial arthritis) (Kuyinu et al. 2016).
low cost, amenability, standardized variants
post-operative management, low translability
chemically- and genetically-induced OA
low costs, similarity with human OA
sedentary behaviour, low translability
spontaneous and chemically-induced OA
low cost, amenability
surgically- and chemically-induced OA
self-regeneration, differences with human anatomy, post-operative management
surgically- and chemically-induced OA
high costs, perception
spontaneous and surgically-induced OA
amenability, radiologic evaluation, large joints
high costs, physiology
high costs, anatomy, perception
spontaneous OA and overuse
Another important aspect to take into account during the study design is the outcome of measurements. Quantitative methods comprise the evaluation of biomarkers, precursors, and products of metabolism released in the serum, urine, and synovial fluid whose levels can correlate with OA changes occurring in the joint. Histopathology and imaging like X-rays and MRI are suitable qualitative methods (Eckstein & Le Graverand 2015) that can be adopted together with appropriate histopathological scores such as the Mankin, O’Driscoll, International Cartilage Repair Society (ICRS), and Osteoarthritis Research Society International (OARSI) scores in order to provide a quantitative interpretation of the results.
In conclusion, translational animal research plays critical roles in helping researchers to understand the mechanisms of the disease, in improving the methods of early detection, and in identifying and investigating potential treatment targets for such a common, complex pathology as OA. From this point of view, it is crucial to identify and apply the most suitable model to each single research purpose in order to maximize translatability and comply with ethical an economical requirements. However, despite the potentiality of these models, the results arising out of preclinical studies have shown poor translation into clinical trials. One of the reasons could be that most studies involve post-traumatic OA, but the generated therapeutic intervention is then used to treat primary OA. Clearly defined post-traumatic OA in humans based on evaluations by MRI and other sensitive imaging approaches may represent a useful, more adapted clinical cohort for proof-of-principle for human trials. Moreover, a non-homogeneous data collection in these studies (animal husbandry conditions, animal gender…) could generate confusion and reduce the reliability of a study comparison. To improve uniformity and make the results more reproducible, it is strongly suggested to follow the Animal Research Reporting of In Vivo Experiments (ARRIVE) guidelines as well as to include skilled researchers, such as veterinary technicians and doctors in the research team.
High tibial osteotomy models
Preclinical large animal models of high tibial osteotomy (HTO) can be used to test different types of osteotomies and to evaluate the effect of lower limb alignment on the reconstructive therapy of cartilage lesions and on the development and progression of OA (Allen et al. 1998, Lobenhoffer & Agneskirchner 2003).
. medial and longitudinal approach to the proximal tibia,
. biplanar osteotomy to increase initial rotatory stability regardless of the direction of correction (Pape et al. 2013),
. small, narrow but long implant with locking screws (small stature HTO plate, Synthes, Umkirch, Germany) (Fig. 8),
. posterior plate placement to avoid slope changes, and
Surgical anatomical parameters relevant for HTO in humans and sheep
Sheep stifle joint
Surgical consequences for the sheep HTO model
Tibial plateau width [mm]
match screw length, narrow and strait plate design necessary
Tibia valga [°]
valgus overcorrection more likely
Knee range of motion [°]
dorsal plate positioning after open wedge HTO suggested due to increased loading of the posterior tibial plateau
Tibial tuberosity dimension adding to the anterio-posterior diameter of the tibial head [%]
anterior plate misplacement more likely
Tibial tuberosity height distance in relation to the joint line [mm]
anterior plate misplacement more likely
Posterior slope of the posterior articular surface [°]
20 ± 3
narrow and straight plate design necessary for posterior placement
Biomechanical properties of the tibial head
elastic cortical bone, exuberant amount of spongious bone
brittle cortical bone, few spongious bone
bicortical proximal screw placement mandatory to avoid fracture and dislocation, biplanar osteotomy mandatory regardless of the desired direction of correction
Musculature of the hind limb
remote from bony knee structures
voluminous on medial and lateral side of the femur
distal femoral and proximal lateral tibial osteotomy almost impossible, stay on the medial side of the proximal tibia for any desired correction angle
lateral ridge extending further laterally and anteriorly
medial ridge extending further cranially and dorsally than lateral ridge
higher propensity of patella instability after valgus correction
Probabilities of potential pitfalls among humans and sheep
Osteonecrosis of proximal fragment
Fracture through proximal fragment with violation of the joint space
Bone cysts without screw perforation
Loss of correction due to implant failure
Although successful HTO in sheep is complex, this model may serve as an elegant model to induce axial malalignment in a clinically relevant environment and osteotomy healing under challenging mechanical conditions due to its similarities with humans.
Mesenchymal stem cells (MSCs) are considered a promising option for the treatment of OA. MSCs are multipotent progenitor cells with capability of self-renewal, high plasticity, immunosuppressive and anti-inflammatory action, and the possibility to differentiate into selected lineages including chondrocytes (Manferdini et al. 2013). Moreover, these cells, derived from perivascular cells called "pericytes", play a key role in the response to tissue injury not only by differentiating themselves but also by inducing repair/regeneration processes at the site of damage through the secretion of several bioactive molecules (Caplan & Correa 2011).
Stem cells for OA treatment: clinical evidence from randomized controlled trials
higher cartilage quality (MRI)
Vega et al. 2015
(low versus high MSCs dose versus HA)
meniscus regeneration (MRI)
Vangsness et al. 2014
(osteotomy and microfracture)
higher cartilage quality (MRI)
Wong et al. 2013
Cadossi et al. 2014
improved cartilage quality (MRI)
Saw et al. 2013
higher cartilage quality (MRI)
Koh et al. 2016
Koh et al. 2014
Basic science results may be useful to understand the suboptimal results obtained clinically so far and to help identifying development strategies for future directions to improve OA treatments. The safety of using MSCs is supported by preclinical studies but some risks have been also underlined such as the possibility of contamination during cell manipulation and the formation of free body and scar tissue in the joint with the transplantation of large cell numbers (Agung et al. 2006). The risk of unwanted differentiation and inadequate aging is another possibility strictly related to the treatment efficacy itself. In fact, signs of hypertrophy have been documented with MSC chondrogenic differentiation: type-X collagen, MMP13, alkaline phosphatase (ALP) are signs of terminal differentiation that may lead to mineralization in vivo and thus to the formation of a low quality cartilage (Hellingman et al. 2012). These findings have been documented not only in bone marrow-derived cells but also when dealing with adipose tissue and even with embryonic stem cells, suggesting that the current culture conditions may be not ideal to guide MSCs toward chondrogenic differentiation. Different strategies have been proposed to inhibit terminal differentiation but nowadays no hyaline cartilage regeneration can be obtained in vitro, yet, and therefore no hyaline cartilage may be expected in vivo (Hellingman et al. 2012). Other indications from the preclinical literature relate to the number of cells and the need for either expansion or concentration. Heterogeneous findings do not allow to drag clear conclusions on this matter but the need to obtain many cells through expansion has been questioned by studies showing similar or even better results through the use of concentrates which may offer a lower number of cells but on the other hand the benefit of administering MSCs in their niche and therefore allowing them to act in more favorable conditions (Perdisa et al. 2015, Wu et al. 2016). Regardless of the cell type and method of manipulation, MSCs are rarely applied in clinical practice alone and platelet concentrates have been frequently associated to their use. Even though no randomized controlled trials has been performed to demonstrate the added benefits of blood-derived products, basic science supports platelet-rich plasma (PRP) combination, showing a synergistic effect through cell-proliferation and extracellular synthesis, anti-inflammatory effects, and in the end lower OA progression (Yun et al. 2016).
In conclusion, the state of the art of MSCs for the treatment of OA shows contrasting findings. While promising results have been obtained in terms of clinical improvement, results are not optimal and there is still a lack of indication on the optimal cell source, processing, and administration modality. Further studies are needed both preclinically to develop appropriate models to further explore the potential of MSCs as well as in the clinical practice through randomized controlled trials to clearly demonstrate the advantages of this biological approach with respect to the other available treatments for OA.
The ideal treatment for OA should control not only the symptoms but also slow down or prevent the degradation of the joint. In this sense, tissue engineering may be a game changer in the treatment of OA as it can possibly create functional substitutes through integrated solutions where scaffolds, cells and drugs/growth factors are used, alone or in combination (Langer and Vacanti 1993).
. they are made of a three-dimensional (3D) permeable polymer network,
. they are produced by a reaction of monomers or by hydrogen bounding,
. they exhibit a hydrophilic structure making them capable of holding large amounts of water (thousands of times their dry weight),
. their mechanical properties (e.g. stiffness) can be tuned according to the application,
. they have free-shapeable properties (bending, knotting stretching, compressing),
. they can be injected in minimally invasive manner,
. they have an ability to encapsulate and control the delivery of cells and growth factors, and
. they are bioadhesive and biocompatible.
Application of hydrogels as cell/drug delivery carriers for OA therapy
injection of autologous MSCs in goat knee joints
(Murphy et al. 2003)
injection of PlnD1-HA to potentiate BMP-2 activity in an experimental murine OA model
(Srinivasan et al. 2012)
injection of beads to reduce OA in rabbits
(Oprenyeszk et al. 2013)
Kartogenin-conjugated chitosan hydrogel
intra-articular delivery to protect against OA in rats
(Kang et al. 2014)
induction of bone marrow-derived MSCs chondrogenesis
(Snyder et al. 2014)
Gelatin hydrogels incorporating rapamycine micelles
intra-articular administration to protect against OA in mice
(Matsuzaki et al. 2014)
CM-SIN and GelMA hydrogels
intra-articular injection to reduce OA in mice
(Chen et al. 2016)
. they can be used as injectable systems for minimally invasive surgeries,
. they allow for gelation in the presence of body fluids within few seconds,
. they display some degree of bioadhesiveness while allowing cells encapsulation, proliferation, and differentiation towards the chondrogenic lineage, and
. they are noncytotoxic.
The methacrylated GG derivative (GGMA) has been synthesized and processed in the form of hydrogel and scaffolds (single or multilayered) to deliver cells and drugs for cartilage regeneration (Pereira et al. 2014). These systems are now also being tested in preclinical assays to provide a valid alternative to hyaluronan in VS strategies and cell delivery for the treatment of early OA. GG-based hydrogel systems are valuable technological platform for the delivery of stem cells using minimally invasive techniques as it is an injectable system that mimics the native cartilage ECM.
. be patient-specific,
. be based on a single step surgical procedure,
. exploit the combination of different cell types (e.g. co-administration of stem cells and chondrocytes) alone or together with growth factors or PRP, and
. use systems with tunable degradation rates for delivery of drugs and cells (drug concentration, cell density, passage, and cell source should be evaluated).
The patient selection is also an important criterion in future clinical trials to dictate the validity and efficacy of the tissue engineering regenerative strategies for safe translation in the daily clinical practice.
Our current knowledge on OA as a severe human disorder for which there is no reliable cure to date has greatly increased from a basic point of view due to the availability of a variety of clinically relevant animal models, involving various, fine mechanisms that involve all the tissues in the joint. The identification of the processes and mediators underlying the initiation and progression of OA provides hope to establish adapted, novel clinical treatments with a strong emphasis on the use of MSCs and on tissue engineering approaches to deliver effective and safe therapeutic compounds in patients in a close future.
The authors wish to thank the presenters, discussion moderators, and all the participants of the ICL16 of the17th ESSKA Congress, May 7th, 2016, Barcelona, Spain for their valuable input and contributions. The authors are also grateful to Henning Madry (Center of Experimental Orthopaedics, Saarland University Medical Center and Saarland University, Homburg/Saar, Germany), Daniel Lajeunesse (Département of Médicine, Université de Montréal, Centre de Recherche du Centre Hospitalier de l’Université de Montréal - CRCHUM, Montréal, Québec, Canada), and Francesca Fabro Fontana and Marco Viganò (Orthopaedic Biotechnology Laboratory, Galeazzi Orthopaedic Institute, Milano, Italy), for helpful discussions. JMO thanks the FCT for the funds provided under the program Investigador FCT 2012 (IF/00423/2012).
MC, LdG, GF, JMO, PO, DP, PR participated equally in drafting the manuscript. MC drafted in particular the Cell-matrix interface in OA section. LdG drafted in particular the Animal models of OA section. GF drafted in particular the Stem cells in OA section. JMO drafted in particular the Tissue engineering in OA section. PO drafted in particular the Bone in OA section. DP drafted in particular the High tibial osteotomy models section. PR drafted in particular the OA pathomechanisms section. All of the authors read and approved the final manuscript.
The authors declare that they have no conflicts of interest associated with this publication and that there has been no financial support for this work that may have influenced its outcome.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Aaron RK, Dyke JF, Ciombor DM, Ballon D, Lee J, Jung E, Tung GA (2007) Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis. Ann N Y Acad Sci 1117:124–137PubMedView ArticleGoogle Scholar
- Abed E, Chan TF, Delalandre A, Martel-Pelletier J, Pelletier JP, Lajeunesse D (2011) R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblasts. Arthritis Rheum 63(12):3865–3875PubMedView ArticleGoogle Scholar
- Abed E, Couchourel D, Delalandre A, Duval N, Pelletier JP, Martel-Pelletier J, Lajeunesse D (2014) Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity. Bone 59:28–36PubMedView ArticleGoogle Scholar
- Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K (2006) Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc 14(12):1307–1314PubMedView ArticleGoogle Scholar
- Allen M, Houlton J, Adams S, Rushton N (1998) The surgical anatomy of the stifle joint in sheep. Vet Surg 27(6):596–605PubMedView ArticleGoogle Scholar
- Amir G, Pirie CJ, Rashad S, Revell PA (1992) Remodelling of subchondral bone in osteoarthritis: a histomorphometric study. J Clin Pathol 45(11):990–992PubMedPubMed CentralView ArticleGoogle Scholar
- Arner EC, Tortorella MD (1995) Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin-1. Arthritis Rheum 38(9):1304–1314PubMedView ArticleGoogle Scholar
- Arnoldi CC, Linderholm H, Müssbichler H (1972) Venous engorgement and intraosseous hypertension in osteoarthritis of the hip. J Bone Joint Surg Br 54(3):409–421PubMedGoogle Scholar
- Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nature Med 19(2):179–192PubMedView ArticleGoogle Scholar
- Bellido M, Lugo L, Roman-Blas JA, Castaneda S, Calvo E, Largo R, Herrero-Beaumont G (2011) Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthritis Cartilage 19(10):1228–1236PubMedView ArticleGoogle Scholar
- Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377(9783):2115–2126PubMedView ArticleGoogle Scholar
- Bouvard B, Abed E, Yéléhé-Okouma M, Bianchi A, Mainard D, Netter P, Jouzeau JY, Lajeunesse D, Reboul P (2014) Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 16(5):459–469PubMedPubMed CentralView ArticleGoogle Scholar
- Brown TD, Johnston JC, Saltzman CL (2006) Post-traumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma 20(10):739–744PubMedView ArticleGoogle Scholar
- Buckland-Wright JC, Macfarlane DG, Fogelman I, Emery P, Lynch JA (1991) Techetium 99 m methylene diphosphonate bone scanning in osteoarthritic hands. Eur J Nucl Med 18(1):12–16PubMedView ArticleGoogle Scholar
- Buckland-Wright JC, Lynch JA, Dave B (2000) Early radiographic features in patients with anterior cruciate ligament rupture. Ann Rheum Dis 59(8):641–646PubMedPubMed CentralView ArticleGoogle Scholar
- Burr DB (2004) Anatomy and physiology of the mineralized tissues: role in the pathogenesis of osteoarthrosis. Osteoarthritis Cartilage 12(Suppl A):S20–S30PubMedView ArticleGoogle Scholar
- Burr DB, Gallant MA (2012) Bone remodelling in osteoarthritis. Nat Rev Rheumatol 8(11):665–673PubMedView ArticleGoogle Scholar
- Burr DB, Radin EL (2003) Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis? Rheum Dis Clin North Am 29(4):675–685PubMedView ArticleGoogle Scholar
- Cadossi M, Buda RE, Ramponi L, Sambri A, Natali S, Giannini S (2014) Bone marrow-derived cells and biophysical stimulation for talar osteochondral lesions: a randomized controlled study. Foot Ankle Int 35(10):981–987PubMedView ArticleGoogle Scholar
- Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9(1):11–15PubMedPubMed CentralView ArticleGoogle Scholar
- Chan TF, Couchourel D, Abed E, Delalandre A, Duval N, Lajeunesse D (2011) Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res 26(7):1399–1410PubMedView ArticleGoogle Scholar
- Chen P, Xia C, Mei S, Wang J, Shan Z, Lin X, Fan S (2016) Intra-articular delivery of sinomenium encapsulated by chitosan microspheres and photo-crosslinked GelMA hydrogel ameliorates osteoarthritis by effectively regulating autophagy. Biomaterials 81:1–13PubMedView ArticleGoogle Scholar
- Christiansen BA, Guilak F, Lockwood KA, Olson SA, Pitsillides AA, Sandell LJ, Silva MJ, van der Meulen MC, Haudenschild DR (2015) Non-invasive mouse models of post-traumatic osteoarthritis. Osteoarthritis Cartilage 23(10):1627–1638PubMedView ArticleGoogle Scholar
- Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, Lajeunesse D (2009) Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum 60(5):1438–1450PubMedView ArticleGoogle Scholar
- Day JS, Ding M, van der Linden JC, Hvid I, Sumner DR, Weinans H (2001) A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage. J Orthop Res 19(5):914–918PubMedView ArticleGoogle Scholar
- de Girolamo L, Kon E, Filardo G, Marmotti AG, Soler F, Peretti GM, Vannini F, Madry H, Chubinskaya S (2016) Regenerative approaches for the treatment of early OA. Knee Surg Sports Traumatol Arthrosc 24(6):1826–1835PubMedView ArticleGoogle Scholar
- Driban JB, Lo GH, Pric L, Pang J, Miller E, Ward RJ, Hunter DJ, Eaton CB, Lynch JA, McAlindon TE, OAI Investigators Group (2013) Bone marrow lesion volume reduction is not associated with improvement of other periarticular bone measures: data from the Osteoarthritis Initiative. Arthritis Res Ther 15(5):R153–R160PubMedPubMed CentralView ArticleGoogle Scholar
- Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, Pottie P (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48(11):3118–3129PubMedView ArticleGoogle Scholar
- Duncan H, Jundt J, Riddle JM, Pitchford W, Christopherson T (1987) The tibial subchondral plate. A scanning electron microscopic study. J Bone Joint Surg Am 69(8):1212–1220PubMedGoogle Scholar
- Dyke JP, Aaron RK (2010) Noninvasive methods of measuring bone blood perfusion. Ann N Y Acad Sci 1192:95–102PubMedPubMed CentralView ArticleGoogle Scholar
- Echtermeyer F, Bertrand J, Dreier R, Meinecke I, Neugebauer K, Fuerst M, Lee YJ, Song YW, Herzog C, Theilmeier G, Pap T (2009) Syndecan-4 regulates ADAMTS-5 actiavtion and cartilage breakdown in osteoarthritis. Nat Med 15(9):1072–1076PubMedView ArticleGoogle Scholar
- Eckstein F, Le Graverand MP (2015) Plain radiography or magnetic resonance imaging (MRI): which is better in assessing outcome in clinical trials of disease-modifying osteoarthritis drugs? Summary of a debate held at the World Congress of Osteoarthritis 2014. Semin Arthritis Rheum 2015(45):251–256View ArticleGoogle Scholar
- Enomoto M, Leboy PS, Menko AS, Boettiger D (1993) Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp Cell Res 205(2):276–285PubMedView ArticleGoogle Scholar
- Filardo G, Madry H, Jelic M, Roffi A, Cucchiarini M, Kon E (2013) Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc 21(8):1717–1729PubMedView ArticleGoogle Scholar
- Filardo G, Perdisa F, Roffi A, Marcacci M, Kon E (2016) Stem cells in articular cartilage regeneration. J Orthop Surg Res 11:42–56PubMedPubMed CentralView ArticleGoogle Scholar
- Forsyth CB, Pulai J, Loeser RF (2002) Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 46(9):2368–2376PubMedView ArticleGoogle Scholar
- Funck-Brentano T, Cohen-Solal M (2011) Crosstalk between cartilage and bone: when bone cytokines matter. Cytokine Growth Factor Rev 22(2):91–97PubMedView ArticleGoogle Scholar
- Gevers G, Dequeker J (1987) Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis. Coll Relat Res 7(6):435–442PubMedView ArticleGoogle Scholar
- Glasson SS, Blanchet TJ, Morris EA (2007) The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15(9):1061–1069PubMedView ArticleGoogle Scholar
- Goldring MB, Goldring SB (2007) Osteoarthritis. J Cell Physiol 213(3):626–634PubMedView ArticleGoogle Scholar
- Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192:230–237PubMedView ArticleGoogle Scholar
- Goldring MB, Otero M (2011) Inflammation in osteoarthritis. Curr Opin Rheumatol 23(5):471–478PubMedPubMed CentralView ArticleGoogle Scholar
- Gregory MH, Capito N, Kuroki K, Stoker AM, Cook JL, Sherman SL (2012) A review of translational animal models for knee osteoarthritis. Arthritis 2012:764621–764634PubMedPubMed CentralView ArticleGoogle Scholar
- Grynpas MD, Alpert B, Katz I, Lieberman I, Pritzker KP (1991) Subchondral bone in osteoarthritis. Calcif Tissue Int 49(1):20–26PubMedView ArticleGoogle Scholar
- Guevremont M, Martel-Pelletier J, Massicotte F, Tardif G, Pelletier JP, Ranger P, Lajeunesse D, Reboul P (2003) Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: potential implication of osteoblasts on the presence of HGF in cartilage. J Bone Miner Res 18(6):1073–1081PubMedView ArticleGoogle Scholar
- Guilak F, Alexopoulos LG, Upton ML, Youn I, Choi JB, Cao L, Setton LA, Haider MA (2006) The pericellular matrix as a transducer of biomechanical and biochemical signals in articular cartilage. Ann N Y Acad Sci 1068:498–512PubMedView ArticleGoogle Scholar
- Heinegård D (2009) Proteoglycans and more -- from molecules to biology. Int J Exp Path 90(6):575–586View ArticleGoogle Scholar
- Heinegård D, Saxne T (2011) The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 7(1):50–56PubMedView ArticleGoogle Scholar
- Hellingman CA, Koevoet W, van Osch GJ (2012) Can one generate stable hyaline cartilage from adult mesenchymal stem cells? A developmental approach. J Tissue Eng Regen Med 6(10):e1–e11PubMedView ArticleGoogle Scholar
- Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D (1998) Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an alterd phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 41(5):891–899PubMedView ArticleGoogle Scholar
- Hunter DJ, Zhang W, Conaghan PG, Hirko K, Menashe L, Li L, Reichman WM, Losina E (2011) Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage 19(5):557–588PubMedPubMed CentralView ArticleGoogle Scholar
- Intema F, Sniekers YH, Weinans H, Vianen ME, Yocum SA, Zuurmond AM, DeGroot J, Lafeber FP, Mastbergen SC (2010) Similarities and discrepancies in subchondral bone structure in two differently induced canine models of osteoarthritis. J Bone Miner Res 25(7):1650–1657PubMedView ArticleGoogle Scholar
- Kang ML, Ko JY, Kim JE, Im GI (2014) Intra-articular delivery of kartogenin-conjugated chitosan nano/microparticles for cartilage regeneration. Biomaterials 35(37):9984–9994PubMedView ArticleGoogle Scholar
- Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502PubMedPubMed CentralView ArticleGoogle Scholar
- Knight MM, McGlashan SR, Garcia M, Jensen CG, Poole CA (2009) Articular chondrocytes express connexion 43 hemichannels and P2 receptors - a putative mechanoreceptor complex involving the primary cilium? J Anat 214(2):275–283PubMedPubMed CentralView ArticleGoogle Scholar
- Knudson CB (1993) Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol 120(3):825–834PubMedView ArticleGoogle Scholar
- Ko FC, Dragomir C, Plumb DA, Goldring SR, Wright TM, Goldring MB, van der Leulen MCH (2013) In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae. Arthritis Rheum 65(6):1569–1578PubMedPubMed CentralView ArticleGoogle Scholar
- Koh YG, Kwon OR, Kim YS, Choi YJ (2014) Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 30(11):1453–1460PubMedView ArticleGoogle Scholar
- Koh YG, Kwon OR, Kim YS, Choi YJ, Tak DH (2016) Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy 32(1):97–109PubMedView ArticleGoogle Scholar
- Kuyinu EL, Narayanan G, Nair LS, Laurencin CT (2016) Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res 11:19–45PubMedPubMed CentralView ArticleGoogle Scholar
- Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, Manes S, Brückner K, Goergen JL, Lemke G, Yancopoulos G, Angel P, Martinez C, Klein R (2001) The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2(5):446–452PubMedPubMed CentralView ArticleGoogle Scholar
- Lam NP, Li Y, Waldman AB, Brussiau J, Lee PL, Olsen BR, Xu L (2007) Age-dependent increase of discoidin domain receptor 2 and matrix metalloproteinase 13 expression in temporomandibular joint cartilage of type IX and type XI collagen-deficient mice. Arch Oral Biol 52(6):579–584PubMedView ArticleGoogle Scholar
- Lampropoulou-Adamidou K, Lelovas P, Karadimas EV, Liakou C, Triantafillopoulos IK, Dontas I, Papaioannou NA (2014) Useful animal models for the research of osteoarthritis. Eur J Orthop Surg Traumatol 24(3):263–271PubMedView ArticleGoogle Scholar
- Langer R, Vacanti JP (1993) Tissue engineering. Science 260(5110):920–925PubMedView ArticleGoogle Scholar
- Lavigne P, Benderdour M, Lajeunesse D, Reboul P, Shi Q, Pelletier JP, Martel-Pelletier J, Fernandes JC (2005) Subchondral and trabecular bone metabolism regulation in canine experimental knee osteoarthritis. Osteoarthritis Cartilage 13(4):310–317PubMedView ArticleGoogle Scholar
- Leitinger B, Kwan AP (2006) The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biol 25(6):355–364PubMedView ArticleGoogle Scholar
- Lim HC, Bae JH, Song HR, Teoh SH, Kim HK, Kum DH (2011) High tibial osteotomy using polycaprolactone-tricalcium phosphate polymer wedge in a micro pig model. J Bone Joint Surg Br 93(1):120–125PubMedView ArticleGoogle Scholar
- Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grassi F, Cavallo C, Facchini A (2006) CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 206(1):78–85PubMedView ArticleGoogle Scholar
- Little CB, Hunter DJ (2013) Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol 9(8):485–497PubMedView ArticleGoogle Scholar
- Lobenhoffer P, Agneskirchner JD (2003) Improvements in surgical technique of valgus high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc 11(3):132–138PubMedGoogle Scholar
- Loeser RF (2014) Integrins and chondrocyte-matrix interactions in articular cartilage. Matrix Biol 39:11–16PubMedPubMed CentralView ArticleGoogle Scholar
- Loeser RF, Goldring SR, Scanzello CR, Goldring MB (2012) Osteoarthritis : a disease of the joint as an organ. Arthritis Rheum 64(6):1697–1707PubMedPubMed CentralView ArticleGoogle Scholar
- Luyten FP, Denti M, Filardo G, Kon E, Engebretsen L (2012) Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 20(3):401–406PubMedView ArticleGoogle Scholar
- Madry H, Kon E, Condello V, Peretti GM, Steinwachs M, Seil R, Berruto M, Engebretsen L, Filardo G, Angele P (2016) Early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 24(6):1753–1762PubMedView ArticleGoogle Scholar
- Malemud CJ, Martel-Pelletier J, Pelletier JP (1987) Degradation of extracellular matrix in osteoarthritis : 4 fundamental questions. J Rheumatol 14:20–22PubMedGoogle Scholar
- Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, Noël D, Lisignoli G (2013) Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum 65(5):1271–1281PubMedView ArticleGoogle Scholar
- Mansell JP, Bailey AJ (1998) Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 101(8):1596–1603PubMedPubMed CentralView ArticleGoogle Scholar
- Martín-Millán M, Castañeda S (2013) Estrogens, osteoarthritis and inflammation. Joint Bone Spine 80(4):368–373PubMedView ArticleGoogle Scholar
- Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, Martel-Pelletier J (2002) Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 10(6):491–500PubMedView ArticleGoogle Scholar
- Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D (2006) Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 8(6):R177–R188PubMedPubMed CentralView ArticleGoogle Scholar
- Matsuzaki T, Matsushita T, Tabata Y, Saito T, Matsumoto T, Nagai K, Kuroda R, Kurosaka M (2014) Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model. Biomaterials 35(37):9904–9911PubMedView ArticleGoogle Scholar
- McCoy AM (2015) Animal models of osteoarthritis: comparisons and key considerations. Vet Pathol 52(5):803–818PubMedView ArticleGoogle Scholar
- McDermott ID, Amis AA (2006) The consequences of meniscectomy. J Bone Joint Surg Br 88(12):1549–1556PubMedView ArticleGoogle Scholar
- McGlashan SR, Jensen CG, Poole CA (2006) Localization of extracellular matrix receptors on the chondrocyte primary cilium. J Histochem Cytochem 54(9):1005–1014PubMedView ArticleGoogle Scholar
- McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A (2010) The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse. Osteoarthritis Cartilage 18(Suppl 3):S93–S105PubMedView ArticleGoogle Scholar
- Miller RE, Lu Y, Tortorella MD, Malfait AM (2013) Genetically engineered mouse models reveal the importance of proteases as osteoarthritis drug targets. Curr Rheumatol Rep 15(8):350–375PubMedPubMed CentralView ArticleGoogle Scholar
- Muhammad H, Rais Y, Miosge N, Ornan EM (2012) The primary cilium as a dual sensor of mechanochemical signals in chondrocytes. Cell Mol Life Sci 69(13):2101–2107PubMedPubMed CentralView ArticleGoogle Scholar
- Murphy M, Fink DJ, Hunziker EB, Barry FP (2003) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48(12):3464–3474PubMedView ArticleGoogle Scholar
- Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M, Lajeunesse D (2010) Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res Ther 12(1):R20–R32PubMedPubMed CentralView ArticleGoogle Scholar
- O’Conor CJ, Ramalingam S, Zelenski NA, Benefield HC, Rigo I, Little D, Wu CL, Chen D, Liedtke W, McNulty AL, Guilak F (2016) Cartilage-specific knockout of the mechanosensory ion channel TRPV4 decreases age-related osteoarthritis. Sci Rep 6:29053. doi:10.1038/srep29053 PubMedPubMed CentralView ArticleGoogle Scholar
- Oliveira JT, Martins L, Picciochi R, Malafaya PB, Sousa RA, Neves NM, Mano JF, Reis RL (2010) Gellam gum: a new biomaterial for cartilage tissue engineering applications. J Biomed Mater Res A 93(3):852–863PubMedGoogle Scholar
- Oprenyeszk F, Chausson M, Maquet V, Dubuc JE, Henrotin Y (2013) Protective effect of a new biomaterial against the development of experimental osteoarthritis lesions in rabbit: a pilot study evaluating the intra-articular injection of alginate-chitosan beads dispersed in an hydrogel. Osteoarthritis Cartilage 21(8):1099–1107PubMedView ArticleGoogle Scholar
- Orth P, Cucchiarini M, Kohn D, Madry H (2013) Alterations of the subchondral bone in osteochondral repair--translational data and clinical evidence. Eur Cell Mater 25:299–316PubMedGoogle Scholar
- Pape D, Madry H (2013) The preclinical sheep model of high tibial osteotomy relating basic science to the clinics: standards, techniques and pitfalls. Knee Surg Sports Traumatol Arthrosc 21(1):228–236PubMedView ArticleGoogle Scholar
- Pape D, Kohn D, Van GN, Hoffmann A, Seil R, Lorbach O (2013) Differences in fixation stability between spacer plate and plate fixator following high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc 21(1):82–89PubMedView ArticleGoogle Scholar
- Pascher A, Palmer GD, Steinert A, Oligino T, Gouze E, Gouze JN, Betz O, Spector M, Robbins PD, Evans CH, Ghivizzani SC (2004) Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 11(2):133–141PubMedView ArticleGoogle Scholar
- Pelletier JP, Cooper C, Peterfy C, Reginster JY, Brandi ML, Bruyère O, Chapurlat R, Cicuttini F, Conaghan PG, Doherty M, Genant H, Giacovelli G, Hochberg MC, Hunter DJ, Kanis JA, Kloppenburg M, Laredo JD, McAlindon T, Nevitt M, Raynauld JP, Rizzoli R, Zilkens C, Roemer FW, Martel-Pelletier J, Guermazi A (2013) What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Ann Rheum Dis 72(10):1594–1604PubMedView ArticleGoogle Scholar
- Perdisa F, Gostyńska N, Roffi A, Filardo G, Marcacci M, Kon E (2015) Adipose-derived mesenchymal stem cells for the treatment of articular cartilage: a systematic review on preclinical and clinical evidence. Stem Cells Int 2015:597652–597665PubMedPubMed CentralView ArticleGoogle Scholar
- Pereira DR, Canadas RF, Silva-Correia J, Marques AP, Reis RL, Oliveira JM (2014) Gellan gum-based hydrogel bilayered scaffolds for osteochondral tissue engineering. Key Eng Mater 587:255–260View ArticleGoogle Scholar
- Pesesse L, Sanchez C, Henrotin Y (2011) Osteochondral plate angiogenesis: a new treatment target in osteoarthritis. Joint Bone Spine 78(2):144–149PubMedView ArticleGoogle Scholar
- Poole CA, Flint MH, Beaumont BW (1988) Chondrons extracted from canine tibial cartilage: preliminary report on their isolation and structure. J Orthop Res 6(3):408–419PubMedView ArticleGoogle Scholar
- Poulet B, Hamilton RW, Shefelbine S, Pitsillides AA (2011) Characterizing a novel and adjustable noninvasive murine joint loading model. Arthritis Rheum 63(1):137–147PubMedView ArticleGoogle Scholar
- Proffen BL, McElfresh M, Fleming BC, Murray MM (2012) A comparative anatomical study of the human knee and six animal species. Knee 19(4):493–499PubMedView ArticleGoogle Scholar
- Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hedge PS, Loeser RF (2005) NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 174(9):5781–5788PubMedPubMed CentralView ArticleGoogle Scholar
- Radin EL, Paul IL, Tolkoff MJ (1970) Subchondral bone changes in patients with early degenerative joint disease. Arthritis Rheum 13(4):400–405PubMedView ArticleGoogle Scholar
- Radin EL, Paul IL, Rose RM (1972) Role of mechanical factors in pathogenesis of primary osteoarthritis. Lancet 1(7749):519–522PubMedView ArticleGoogle Scholar
- Reboul P, Pelletier JP, Tardif G, Benderdour M, Ranger P, Bottaro DP, Martel-Pelletier J (2001) Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade. Arthritis Rheum 44(1):73–84PubMedView ArticleGoogle Scholar
- Ringe J, Burmester GR, Sittinger M (2012) Regenerative medicine in rheumatic disease-progress in tissue engineering. Nat Rev Rheumatol 8(8):493–498PubMedView ArticleGoogle Scholar
- Ruhlen R, Marberry K (2014) The chondrocyte primary cilium. Osteoarthritis Cartilage 22(8):1071–1076PubMedView ArticleGoogle Scholar
- Sanchez C, Deberg MA, Bellahcène A, Castronovo V, Msika P, Delcour JP, Crielaard JM, Henrotin YE (2008) Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum 58(2):442–455PubMedView ArticleGoogle Scholar
- Saw KY, Anz A, Siew-Yoke JC, Merican S, Ching-Soong Ng R, Roohi SA, Ragavanaidu K (2013) Articular cartilage regeneration with autologous peripheral blood stem cells versus hyapuronic acid: a randomized controlled trial. Arthroscopy 29(4):684–694PubMedView ArticleGoogle Scholar
- Shao YY, Wang L, Welter JF, Ballock RT (2012) Primary cilia modulate Ihh signal transduction in response to hydrostatic loading of growth plate chondrocytes. Bone 50(1):79–84PubMedView ArticleGoogle Scholar
- Sniekers YH, Intema F, Lafeber FP, van Osch GJ, van Leeuwen JP, Weinans H, Mastbergen SC (2008) A role for subchondral bone changes in the process of osteoarthritis: a micro-CT study of two canine models. BMC Musculoskelet Disord 9:20–30PubMedPubMed CentralView ArticleGoogle Scholar
- Snyder TN, Madhavan K, Intrator M, Dregalla RC, Park D (2014) A fibrin/hyaluronic acid hydrogel for the delivery of mesenchymal stem cells and potential for articular cartilage repair. J Biol Eng 8(1):1–11View ArticleGoogle Scholar
- Srinivasan PP, McCoy SY, Jha AK, Yang W, Jia X, Farach-Carson MC, Kirn-Safran CB (2012) Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis. Biomed Mater 7(2):024109–024120PubMedPubMed CentralView ArticleGoogle Scholar
- Stanton H, Ung L, Fosang AJ (2002) The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem J 364(Pt 1):181–190PubMedPubMed CentralView ArticleGoogle Scholar
- Suri S, Walsh DA (2012) Osteochondral alterations in osteoarthritis. Bone 51(2):204–211PubMedView ArticleGoogle Scholar
- Taylor SE, Shah M, Orriss IR (2014) Generation of rodent and human osteoblasts. Bonekey Rep 3:585–594PubMedPubMed CentralView ArticleGoogle Scholar
- van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB (2009) TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 17(12):1539–1545PubMedView ArticleGoogle Scholar
- Vangsness CT Jr, Farr J 2nd, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M (2014) Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blin, controlled study. J Bone Joint Surg Am 96(2):90–98PubMedView ArticleGoogle Scholar
- Vega A, Martin-Ferrero MA, Del Canto F, Alberca M, Garcia V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, Sanchez A, Garcia-Sancho J (2015) Tretament of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controller trial. Transplantation 99(8):1681–1690PubMedView ArticleGoogle Scholar
- Vilela CA, Correia C, Oliveira JM, Sousa RA, Espregueira-Mendes J, Reis RL (2015) Cartilage repair using hydrogels: a critical review of in vivo experimental designs. ACS Biomater Sci Eng 1(9):726–739View ArticleGoogle Scholar
- Wilusz RE, Sanchez-Adams J, Guilak F (2014) The structure and function of the pericellular matrix of articular cartilage. Matrix Biol 39:25–32PubMedView ArticleGoogle Scholar
- Wong KL, Lee KB, Tai BC, Law P, Lee EH, Hui JH (2013) Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial oateotomy: a prospective, randomized controlled clinical trial with 2 years follow-up. Arthroscopy 29(12):2020–2028PubMedView ArticleGoogle Scholar
- Wu L, Prins HJ, Leijten J, Helder MN, Evseenko D, Moroni L, van Blitterswijk CA, Lin Y, Karperien M (2016) Chondrocytes cocultured with stromal vascular fraction of adipose tissue present more intense chondrogenic characteristics than with adipose stem cells. Tissue Eng Part A 22(3–4):336–348PubMedView ArticleGoogle Scholar
- Xu L, Peng H, Glasson S, Lee PL, Hu K, Ijiri K, Olsen BR, Goldring MB, Li Y (2007) Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum 56(8):2663–2673PubMedView ArticleGoogle Scholar
- Xu L, Hayashi D, Roemer FW, Felson DT, Guermazi A (2012) Magnetic resonance imaging of subchondral bone marrow lesions in association with osteoarthritis. Semin Arthritis Rheum 42(2):105–118PubMedPubMed CentralView ArticleGoogle Scholar
- Yan JY, Tian FM, Wang WY, Cheng Y, Xu HF, Song HP, Zhang YZ, Zhang L (2014) Age dependent changes in cartilage matrix, subchondral bone mass, and estradiol levels in blood serum, in naturally occurring osteoarthritis in Guinea pigs. Int J Mol Sci 15(8):13578–13595PubMedPubMed CentralView ArticleGoogle Scholar
- Yang L, Tsang KY, Tang HC, Chan D, Cheah KS (2014) Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation. Proc Natl Acad Sci USA 111(33):12097–12102PubMedPubMed CentralView ArticleGoogle Scholar
- Yun S, Ku SK, Kwon SY (2016) Adipose-derived mesenchymal stem cells and platelet-rich plasma synergistically ameliorate the surgical-induced osteoarthritis in Beagle dogs. J Orthop Surg Res 11:9–20PubMedPubMed CentralView ArticleGoogle Scholar
- Zhou X, von der Mark K, Henry S, Norton W, Adams H, de Crombrugghe B (2014) Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet 10(12):e1004820–e1004839PubMedPubMed CentralView ArticleGoogle Scholar